PHARMA-SKAN ApS: Financial statements 2016
CVR: 16275247
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
PHARMA-SKAN ApS (CVR 16275247) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 13,236,971 and a net result of DKK 9,967,894 compared with DKK 11,200,711 the year before. That is a decrease of 11.7% compared with the year before. Equity in the 2016 report amounted to DKK 15,287,828. The solvency ratio was 36.8%. The company had 11 employees in the financial year.
- Gross Profit
- DKK 13,236,971
- Profit/Loss
- DKK 9,967,894
- Equity
- DKK 15,287,828
- Total Assets
- DKK 41,574,935
- Employees
- 11
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 13.2 mio. | 10 mio. | 15.3 mio. | 11 |
| 2015 | - | 15 mio. | 11.2 mio. | 15.3 mio. | 10 |
| 2014 | - | 11.5 mio. | 8.3 mio. | 14.1 mio. | 8 |
| 2013 | - | 11.4 mio. | 8.2 mio. | 15.8 mio. | 9 |
| 2012 | - | 11.6 mio. | 8.4 mio. | 17.6 mio. | 10 |
Official annual report
Find more companies like PHARMA-SKAN ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
PHARMA-SKAN ApS has published its annual report for 2015. Gross profit came to DKK 14,994,922, and the net result was DKK 11,200,711.
About PHARMA-SKAN ApS
PHARMA-SKAN ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ApS KBUS 38 NR. 2587. The management consists of Line Wulff and Ib Gunnar Christensen. The board consists of Jan Dam (chair), Kent Ernst Hansen, Lars Enghave Minor and Line Wulff. The company is owned by BESULA ApS. The company has 16 employees (2018). In 2025, the company reported a gross profit of DKK 12,339,941 and a net result of DKK 7,875,190 compared with DKK 11,288,304 the year before. Equity in the 2025 report amounted to DKK 8,543,005.